We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.14% | 35.45 | 35.20 | 35.60 | 35.65 | 35.20 | 35.45 | 246,675 | 16:35:25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.14 | 105.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/1/2023 19:57 | LiarBO squawked, 'So now the ramper is saying saying real science based on adequately controlled and blinded studies is ‘nonsense̵ Does he not know that some people also supposedly recovered from COVID after just getting the placebo vaccine too! Why doesn’t he buy shares in that placebos too!? ROFLMAO' Hahahahaha! Is that what I said? Or did I say that you comparing Ivermectin with MED3000 was nonsense? Honestly, LiarBO, you really must be careful about all the lies you tell, you just can't keep up with them, can you? And get a grip of your writing too. This childish and uneducated rubbish that you come out with when you're all excited is difficult to follow. | petroc | |
02/1/2023 19:50 | So now the ramper is saying saying real science based on adequately controlled and blinded studies is all ‘nonsense&rsqu Does he not know that some people also supposedly recovered from COVID after just getting the placebo vaccine too! Why doesn’t he buy shares in that placebos too!? ROFLMAO What happened next gets to the FTCs allegation that the respondents, in effect, deceptively sliced and diced the data in search of a positive marketing message. According to the complaint, the respondents subjected the data to post hoc analyses of different subgroups of test subjects. (The complaint describes a post hoc analysis as statistical analysis conducted after the data have been collected in hopes of discovering statistical relationships that suggest cause and effect.) The FTC concern is that unplanned, post hoc subgroup analyses pose a high risk of generating spurious findings. Bias and Fraud There are numerous biases in medical research that render evidence from such research systematically misleading. Some of these biases are exacerbated by conflicts of interest, including fantastic financial incentives. The most important biases in medical research include confirmation bias, design bias, analysis bias, and publication bias. Arguably, some forms of bias, such as publication bias, should be considered as fraud. The pervasiveness of bias in medical research justifies one of the premises of the master argument for medical nihilism. Medical research is malleable due to the many biases, and such malleability allows for the production of evidence that suggests medical interventions are effective, whether or not they are in fact effective. What method-issues to consider when assessing Risk of Bias Concealment of randomization Those enrolling patients are aware of the group (or period in a cross-over trial) to which the next enrolled patient will be allocated (major problem in “ps Blinding Patient, caregivers, those recording outcomes, those adjudicating outcomes, or data analysts are aware of the arm to which patients are allocated (or the medication currently being received in a cross-over trial) Loss to follow-up Loss to follow-up and failure to adhere to the intention to treat principle in superiority trials; or, in non-inferiority trials, loss to follow-up and failure to conduct both analyses considering only those who adhered to treatment, and all patients for whom outcome data are available Selective outcome reporting Incomplete or absent reporting of some outcomes and not others on the basis of the results Use of unvalidated outcome measures (e.g., patient-reported outcomes) | lbo | |
02/1/2023 18:45 | The term stock basher refers to a person who engages in market manipulation to make the price of an asset fall. Stock bashers rely on misinformation campaigns to decrease confidence in a stock, leading to an undervaluation of that security. In LiarBO's case, his manipulation is clear to see. He has nothing on MED3000 that might indicate it doesn't work, which is why he resorts to comments about Ivermectin, Flexiseq, and hundreds of gels and creams which he states are the same as MED3000. | petroc | |
02/1/2023 18:05 | Seems you ‘ loathe to give any credence to virtually everything’ anyone says who is linked to Futura! LOL mikethebike4 - 11 Apr 2018 - 14:35:10 - 4072 of 11141 Having had similar waffling, 'smoke-screen' answers from Mr Barder over the years which have turned out to end in exactly nothing I am loathe to give any credence to virtually everything he says mikethebike4 - 11 Apr 2018 - 15:58:28 - 4091 of 11141 Company is massively over valued if you go by 'concrete' results ! mikethebike4 - 11 Apr 2018 - 15:14:56 - 4082 of 11141 I only try and bring some sort of balance into the equation to help the gullible not get carried away with fanciful future projections. I would like nothing better than to be proved wrong about Mr Barder (our CEO since 2001) and to sale away into the sunset grasping 5 times as many £s in my fist as I paid for the shares Unfortunately for people like J7J, Mr Barder has been through this advisors process before - with CSD500 - and look where we've got in 17 years - sales of the product did not even equal the money we paid him to be our CEO for 2017 ! mikethebike4 - 06 Dec 2017 - 10:32:27 - 3468 of 10591 "A couple of decent deals and will be back off to the races." Do you have any idea of how long shareholders have been using these words mikethebike4 - 23 Mar 2017 - 09:52:33 - 2560 of 10591 As someone who has been invested for many years and who attended an AGM years ago and complained to Barder about the very slow progress, I am very frustrated. All the time the Board are drawing good salaries off the backs of shareholders money they have very little incentive to get off their backsides and get 'selling' - thats what running a company is all about at the end of the day! mikethebike4 - 24 Feb 2020 - 09:11:58 - 7290 of 9713 why should it be any different this time when you've still got the same useless lot running the show mikethebike4 - 07 Jan 2019 - 11:22:52 - 4692 of 9641 I repeat I very much hope you are right - no one would be happier than me if you are - however I stupidly (in hindsight) bought in when everything looked really rosy - we were told there were loads of 'distributors' all 'champing at the bit to get selling a wonderful industry disruptive product (which it still is incidentally) once the 2 year shelf-life problem was fixed. This was despite the fact that the Holland/Belgium distributor was quite happy and successful selling them with the original 18 months shelf-life And where are we now years later - one tiny distributor from which Futura receives a total sales income only just about covering Mr Barders employment remuneration I just hope this MED/TPR situation is not just a repeat of CSD. As to why I don't just sell up, well my shareholding is worth such a tiny proportion of what I paid for it I might just as well hang on in the hope that new shareholders getting in now are luckier than I was and I can get some of my money back - I think what we need is Mr Barders retirement - that should give the share price a kick | lbo | |
02/1/2023 17:29 | The term stock basher refers to a person who engages in market manipulation to make the price of an asset fall. Stock bashers rely on misinformation campaigns to decrease confidence in a stock, leading to an undervaluation of that security. In LiarBO's case, his manipulation is clear to see. He has nothing on MED3000 that might indicate it doesn't work, which is why he resorts to comments about Ivermectin, Flexiseq, and hundreds of gels and creams which he states are the same as MED3000. | petroc | |
02/1/2023 16:52 | Spontaneous Remission and the Placebo Effect When someone feels better after using a product or procedure, it is natural to credit whatever was done. However, this is unwise. Most ailments are self-limiting, and even incurable conditions can have sufficient day-to-day variation to enable quack methods to gain large followings. Taking action often produces temporary relief of symptoms (a placebo effect). In addition, many products and services exert physical or psychologic effects that users misinterpret as evidence that their problem is being cured. These “Dr. Feelgoodâ€? modalities include pharmacologically active herbal products, quack formulas adulterated with prescription drugs, colonic irrigations (which some people enjoy), bodywork, and meditation. Scientific experimentation is almost always necessary to establish whether health methods are really effective. Thus it is extremely important for consumers to understand the concepts of spontaneous remission and the placebo effect. Spontaneous Remission Recovery from illness, whether it follows self-medication, treatment by a scientific practitioner, or treatment by an unscientific practitioner, may lead individuals to conclude that the treatment received was the cause of the return to good health. As noted by Medical historian James Harvey Young, Ph.D.: Will a kind doctor help you feel better? ‘The placebo effect where medication can make you feel better because you think it will, even if it doesn’t have active ingredients has been an area of fascination for decadesâ€&trade randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups? A protocol for a meta-epidemiological study of PDE-5 inhibitors | lbo | |
02/1/2023 16:44 | LOL ‘all involved small numbers of people. This is problematic, as most people recover from their episode of COVID whether treated or not’ Just like all the Med3000 deficient tests ‘involved small numbers’ and you proved yourself that ‘most people recover from their episode’ of psychogenic ED ‘whether treated or not’ petroc8 Dec '22 - 18:26 - 14487 of 14511 Most common reasons for the discontinuation ˜spontaneous recovery of erectile function without further treatment’ The placebo effect is that observed in the placebo arm of a clinical trial, and is produced by the placebo psychobiological phenomenon in addition to other factors, such as spontaneous remission, regression to the mean, biases, and judgment errors. Uncontrolled Trials This design incorporates no control arm. This design is usually utilized to determine pharmacokinetic properties of a new drug (Phase 1 trials). Uncontrolled trials are known to produce greater mean effect estimates than a controlled trial, thereby inflating the expectations from the intervention. There is a threat of inherent bias and results are considered less valid than RCT. Another issue is use of this design in spontaneously resolving maladies that might again overstate the effect | lbo | |
02/1/2023 16:41 | The term stock basher refers to a person who engages in market manipulation to make the price of an asset fall. Stock bashers rely on misinformation campaigns to decrease confidence in a stock, leading to an undervaluation of that security. In LiarBO's case, his manipulation is clear to see. He has nothing on MED3000 that might indicate it doesn't work, which is why he resorts to comments about Ivermection, Flexisec, and hundreds of gels and creams which he states are the same as MED3000. | petroc | |
02/1/2023 16:18 | https://www.ftc.gov/ | lbo | |
02/1/2023 16:09 | Next Petroc will be claiming Ivermectin is still a proven effective treatment for COVID because some people gave testimonials that they associated getting better when taking it! ROFLMAO folks observed that some who took Ivermectin did not get sicker and concluded its benefit. There were even lab studies that hinted at a benefit. But all involved small numbers of people. This is problematic, as most people recover from their episode of COVID whether treated or not. petroc8 Dec '22 - 18:26 - 14487 of 14511 Most common reasons for the discontinuation ˜spontaneous recovery of erectile function without further treatment’ The research Petroc linked also highlighted ˜independent factors influencing discontinuation of the drug were cause of ED (psychogenic’ and ˜The proportion of the patients with psychogenic ED in the discontinuation group (47.4%) was significantly greater’ | lbo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions